Samnyte Tattoo Numbing Creams Recalled Due to Failure to Meet Child-Resistant Packaging Requirement; Sold Exclusively... — CPSC recall 23070

Published notice; closure not supplied

The CPSC record supplies a notice and remedy, not a current closure determination.

Source date Dec 15, 2022. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
The recall involves Samnyte Tattoo Numbing Cream sold in 60ml and contains Lidocaine 5% with Vitamin E. The product was sold in a white tube with a flip-top closure. The drug facts label is on the back.
Reason
The packaging is not child resistant as required by the Poison Prevention Packaging Act. The tattoo numbing cream contains lidocaine, posing a risk of poisoning to young children if they ingest it.
Classification
Not supplied
Recalling firm
Sainite Trading (Shenzhen) Co. LTD, of China; Liu Xianli (Amazon Storefront: Tattoo Castle USA), of Staten Island, New York
Quantity
About 9,000
Agency-reported status
Published recall notice
Source record identifier
23070

Open the official record

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityRead the product description and official photos for model and lot identifiers.

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

Not supplied

No US distribution state could be established from this record. Check the official notice.

Dates in the source

Last publish date
Dec 15, 2022

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records